S.Korea's total COVID cases top 10 million as crematoria, funeral homes
overwhelmed
Send a link to a friend
[March 23, 2022]
By Hyonhee Shin
SEOUL (Reuters) - South Korea's total
coronavirus infections topped 10 million, or nearly 20% of its
population, authorities said on Wednesday, as surging severe cases and
deaths increasingly put a strain on crematories and funeral homes
nationwide.
The country has been battling a record COVID-19 wave driven by the
highly infectious Omicron variant even as it largely scrapped its once
aggressive tracing and quarantine efforts and eased social distancing
curbs.
The Korea Disease Control and Prevention Agency (KDCA) reported 490,881
cases for Tuesday, the second highest daily tally after it peaked at
621,205 on March 16. The total caseload rose to 10,427,247, with 13,432
deaths, up 291 a day before.
The country's infection and death rates are still far below those
recorded elsewhere, as almost 87% of its 52 million residents are fully
vaccinated and 63% have received booster shots.
But the death toll nearly doubled in just about six weeks, with daily
fatalities peaking at 429 last Friday, fuelling demand for funeral
arrangements.
The health ministry on Monday instructed the 60 crematories nationwide
to operate for longer hours to burn up to seven bodies from five, and
the 1,136 funeral parlours capable of storing some 8,700 bodies to
expand their facilities.
"Crematories' capacity is increasing," ministry official Son Young-rae
said. "But there are still regional differences."
Authorities have already boosted the combined daily cremation capacity
from about 1,000 to 1,400 per day starting last week. But a large
backlog of bodies and a long wait continued to be reported in the
densely populated greater Seoul area, Son said.
Health ministry data showed that the 28 crematories in Seoul city were
operating at 114.2% capacity as of Monday, while the ratio stood at
about 83% in other regions such as Sejong and Jeju.
[to top of second column]
|
People wait in line to undergo the coronavirus disease (COVID-19)
test at a testing site which is temporarily set up at a public
health center in Seoul, South Korea, February 24, 2022. REUTERS/Heo
Ran/File Photo
Crematories will be temporarily
allowed to receive reservations from outside their regions, which is
currently banned by some local governments, to ease the pileup, Son
said.
The number of critically ill patients has been
hovering above 1,000 over the past two weeks, but it could go up to
2,000 in early April, another health ministry official Park Hyang
said. Around 64.4% of the intensive care unit beds are occupied as
of Wednesday, compared with some 59% two weeks earlier.
As part of efforts to curb severe cases and deaths, South Korea's
drug safety agency granted emergency approval for the use of Merck &
Co Inc's COVID-19 treatment pill for adults.
The molnupiravir tablet, branded as Lagevrio, is the second oral
antiviral to be authorised in South Korea after Pfizer Inc's
Paxlovid.
Lagevrio will only be allowed for patients who are aged 18 or older
and not pregnant and cannot be treated with injection medications or
the highly effective Paxlovid, the drug safety agency said.
The health ministry said the first shipment of Lagevrio pills for
20,000 people is expected to arrive on Thursday.
"The medical system is under substantial pressure, though it is
still operated within a manageable range," Park told a briefing on
Wednesday.
"We would focus more on high risk groups going forward, and make
constant checks to ensure that there is no blind spot."
(Reporting by Hyonhee Shin; Editing by Michael Perry)
[© 2022 Thomson Reuters. All rights
reserved.] This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|